Fujifilm completes SonoSite buy; HeartWare agrees to buy World Heart for $8M;

@FierceMedDev: Globus Medical files for IPO of up to $100 million via @reutersItem | Follow @FierceMedDev

> Fujifilm has completed its acquisition of SonoSite ($SONO). As a result, SonoSite will become a wholly-owned subsidiary of Fujifilm, and its stock will no longer be traded on the NASDAQ Global Select Market. Fujifilm release

> HeartWare International ($HTWR), which makes miniaturized ventricular assist devices, has agreed to buy World Heart Corporation ($WHRT) for $8 million. HeartWare release

> Abbott Labs ($ABT) has snagged CE Mark approval to market its rapid, high-throughput PLEX-ID instrument, along with three assays for use on the system: PLEX-ID Viral IC Spectrum, PLEX-ID BAC Spectrum BC and PLEX-ID Flu. Abbott release

> GE Healthcare ($GE) is looking to pump up sales in China's grassroots market to half of its business in the nation within 5 years. Currently, that number stands at less than 20%. GE Healthcare China President and CEO Rachel Duan said the company hopes to launch 32 new products there over the next three to four years. Report

> Almac has signed an exclusive global distribution deal with Affymetrix related to the Xcel array for biomarker discovery, development and delivery. Almac release

> Optos has delivered the first Daytona retinal imaging tech to customers. Optos release

And Finally...  Princeton University researchers have developed a sensor that could be tattooed on a patient's tooth to detect infection and transmit data to medical professionals. News

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.